Use of cpg oligonucleotides in the treatment of hepatitis c...

Details Use of cpg oligonucleotides in the treatment of hepatitis c... Use of cpg oligonucleotides in the treatment of hepatitis c...

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61K 31/7088 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2503693

The invention provides methods for identifying and treating subjects having hepatitis C infections. In some instances, the subjects are those that are non- responsive to non-CpG therapy. Preferably, the subjects are treated with C class CpG immunostimulatory nucleic acids having a semi-soft backbone.

La présente invention concerne des techniques d'identification et de traitement de sujets infectés par le virus de l'hépatite C. Dans certains cas, les sujets sont ceux qui ne réagissent pas à une thérapie non CpG. Ces sujets sont, de préférence, traités avec des acides nucléiques immunostimulateurs CpG de classe C possédant un squelette semi-rigide

Affiliated with

Also associated with

Rating

Use of cpg oligonucleotides in the treatment of hepatitis c... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cpg oligonucleotides in the treatment of hepatitis c..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cpg oligonucleotides in the treatment of hepatitis c... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1412711